SMARCA4 and cancer: The Blueprint Genetics (BpG) Hereditary Pediatric Cancer Panel identified a heterozygous frameshift variant, SMARCA4 c.2693del, p.(Asn898Thrfs*12), which has not been previously described in the medical literature, reported in disease-related variation databases such as ClinVar or HGMD, and is absent in gnomAD.